Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through
Francisco J Molina Estevez1, Tyler D Mathews1, Alessandra Biffi2
1Dana-Farber/Boston Children's Cancer and Blood Disorders Center.
Journal of Visualized Experiments : Jove
|December 10, 2019
Summary
Researchers developed a flow cytometry protocol to quantify cell types in the central nervous system (CNS). This method aids in optimizing viral vector and nanoparticle delivery for neuroscientific research.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Viral vectors and nanomaterials offer novel ways to study the central nervous system (CNS).
- Optimizing these tools requires methods to assess CNS and cell-specific targeting.
- Current methods may not efficiently quantify cell subtypes after administration.
Purpose of the Study:
- To present a high-throughput flow cytometry protocol for quantifying CNS cell subtypes.
- To compare tissue homogenization methods for cell yield, viability, and composition.
- To provide a tool for optimizing viral vector and nanoparticle delivery in the CNS.
Main Methods:
- Isolation of single-cell suspensions from mouse brain and spinal cord.
- Utilizing flow cytometry for high-throughput, multiplexed cell quantification.
- Analysis of microglia/macrophages, lymphocytes, astrocytes, oligodendrocytes, neurons, and endothelial cells.
Main Results:
- The protocol enables straightforward quantification of diverse CNS cell subtypes.
- Differences in cell yield, viability, and composition were observed between two homogenization methods.
- The choice of homogenization method impacts cell recovery and suitability for downstream applications.
Conclusions:
- The developed flow cytometry protocol is valuable for neuroscientists studying CNS targeting.
- It facilitates the selection of optimal tissue processing methods based on cell type and application.
- This method supports cell sorting for further analyses like gene expression and functional assays in neurodegenerative diseases, pharmacology, and gene therapy.


